Switch View
© BusinessWire
07.11.2025
ISIN: US3596641098
Fulgent Genetics Inc
FLGT
LISTED
NASDAQ
Fulgent Reports Third Quarter 2025 Financial Results
News Preview
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its third quarter ended September 30, 2025.
Third Quarter 2025 Results:
Revenue of $84.1 million, growing 17% year-over...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US15117B1035
Celldex Therapeutics, Inc.
CLDX
LISTED
NASDAQ
Celldex to Present at Upcoming Investor Conferences
News Preview
HAMPTON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US49372L2097
Kezar Life Sciences Inc
KZR
LISTED
NASDAQ
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
News Preview
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced two presentations from the completed Phase 2a PORTOLA clinical trial in patients with autoimmune hepatitis (AIH) at The Liver Meeting 2025 held by the America...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
07.11.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review
News Preview
Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years and older compared to placebo...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
07.11.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025
News Preview
MADRID and CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today reported financial results for the nine months ended September 30, 2025 and provided a corporate update on recent developments....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US92243A2006
Vaxart Inc
VXRT
LISTED
NASDAQ
Vaxart to Host Upcoming Conference Calls
News Preview
Third quarter 2025 results conference call to be held on November 13 at 4:30 p.m. ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review
News Preview
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US04683R1068
Atea Pharmaceuticals Inc
AVIR
LISTED
NASDAQ
Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025
News Preview
Company Hosting Virtual KOL Panel Event Thursday, November 13th at 10:00 AM ET Company Hosting Virtual KOL Panel Event Thursday, November 13th at 10:00 AM ET...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: CA12675Q1019
C21 Investments Inc.
CXXI
LISTED
CSE
C21 Investments to Report Second Quarter Financial Results on November 11, 2025
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced it will release its financial results for the second quarter ended September 30, 2025, on Tuesday, November 11, 2025, before market open.For further in...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet
News Preview
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the second quarter ended September 30, 2025 ("Q2 FY2026"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
“We’re building a stronger, more competitive company...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qual...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
agilon Announces Receipt of Notice of Non-Compliance with the NYSE Continued Listing Standards
News Preview
agilon health, inc. (the “Company”) (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that the New York Stock Exchange (the “NYSE”) issued a notice (the “Notice”) on November 5, 2025 informing the Company that it is no longer in compliance with its continued listing standards becaus...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
07.11.2025
ISIN: US6359061008
National Healthcare Corp
NHC
LISTED
XASE
NHC Reports Third Quarter 2025 Earnings
News Preview
National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended September 30, 2025 totaled $382,661,000 compared to $340,198,000 for the quarter ended September 30, 2024, an increase of 12.5%. The increase in net operating revenues fo...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US91324P1021
UnitedHealth Group Inc
UNH
LISTED
NYSE
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
News Preview
The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on December 16, 2025, to all shareholders of record of UNH common stock as of the close of business December 8, 2025.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US76243J1051
Rhythm Pharmaceuticals Inc
RYTM
LISTED
NASDAQ
Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
News Preview
-- FDA sets updated PDUFA goal date of March 20, 2026 – ...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on November 3, 2025, the Compensation Committee of the Company’s Board of Directors (the “Compensati...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
News Preview
Post-hoc analyses corroborate previously reported antifibrotic effects of efruxifermin observed in 96-week Phase 2b SYMMETRY trial and indicate potential to reduce risk of disease progression in compensated cirrhosis (F4c) due to MASH...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US81578P1066
Seer Inc
SEER
LISTED
NASDAQ
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
News Preview
Studies spanning cardiovascular, aging, and cancer biology highlight how Seer’s Proteograph® platform is enabling discovery at population scale Studies spanning cardiovascular, aging, and cancer biology highlight how Seer’s Proteograph® platform is enabling discovery at population scale...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US74168J1016
Prime Medicine Inc
PRME
LISTED
NASDAQ
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
News Preview
-- New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial clinical data expected in 2027 -- -- Nominated PM647 as development candidate for Alpha-1 Antitrypsin Deficiency (AATD); on-track to file IND and/or CTA in mid-2026, with initial clinical data expected in 2027...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US67576A1007
Ocular Therapeutix Inc
OCUL
LISTED
NASDAQ
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BEDFORD, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to one newly hired non-executive employee. The award was made as an inducement material to the individual’...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Yolk's Breakfast Announces Grand Opening of Newest Location in Toronto's Bloor West Village
News Preview
Toronto, Ontario--(Newsfile Corp. - November 7, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that further to its July 7th, 2025, news release announcing the signing of a franchise agreement and real estate location for Y...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US00182C1036
ANI Pharmaceuticals Inc
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance
News Preview
PRINCETON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US0094961002
AirSculpt Technologies Inc
AIRS
LISTED
NASDAQ
AirSculpt Technologies Reports Third Quarter Fiscal 2025 Results
News Preview
MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US80303D3052
SANUWAVE Health, Inc.
SNWV
LISTED
NASDAQ
Sanuwave Announces Q3 FY2025 Financial Results
News Preview
Sanuwave Announces Q3 FY2025 Financial Results...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US75340L1044
Rapid Micro Biosystems Inc
RPID
LISTED
NASDAQ
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
News Preview
LEXINGTON, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the third...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US4037831033
Gyre Therapeutics Inc
CBIO
LISTED
NASDAQ
Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update
News Preview
Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
07.11.2025
ISIN: US51654W1018
Lantern Pharma Inc.
LTRN
LISTED
NASDAQ
Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows
News Preview
NEW YORK, NY / ACCESS Newswire / November 7, 2025 / New to The Street, one of America's leading business television and multi-platform media brands, today announced a comprehensive media partnership with Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence company developing cancer medicines with multiple clinical-stage programs.The collab...
Themefolio
Profiler
Peergroup
© EQS Newswire
07.11.2025
ISIN: DE000STRA555
Stratec Se
SBS
LISTED
XETR
STRATEC REPORTS DEFINITIVE RESULTS FOR FIRST NINE MONTHS OF 2025
News Preview
STRATEC REPORTS DEFINITIVE RESULTS FOR FIRST NINE MONTHS OF 2025
Despite supply chain-induced interruption to production, consolidated sales at constant currency up 2.5% (nominal: +1.5%) to € 175.6 million in 9M/2025 (9M/2024: € 173.0 million)
Scale effects and higher earnings contributions from the realization of high-margin development sales a......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.11.2025
ISIN: DE000STRA555
Stratec Se
SBS
LISTED
XETR
STRATEC BERICHTET FINALE ZAHLEN FÜR DIE ERSTEN NEUN MONATE 2025
News Preview
STRATEC BERICHTET FINALE ZAHLEN FÜR DIE ERSTEN NEUN MONATE 2025
Entgegen lieferkettenbedingter Produktionsunterbrechung Steigerung des Konzernumsatzes 9M/2025 um währungsbereinigt +2,5% (nominal: +1,5%) auf 175,6 Mio. € (9M/2024: 173,0 Mio. €)
Skaleneffekte sowie prognostizierte höhere Ergebnisbeiträge aus der Realisierung margenstarker Entwickl......
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Savara Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SVRA
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the "Class Period"), of the important November 7, 2025 lead plaintiff deadline.SO WHAT: If you purchased S...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LANTHEUS DEADLINE: ROSEN, A RANKED AND LEADING FIRM, Encourages Lantheus Holdings, Inc. Investors to Secure Counsel Before Important November 10 Deadline in Securities Class Action - LNTH
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), of the important November 10, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action - JSPR
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOH
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline.SO WHAT: If yo...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline.SO WHA...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)
News Preview
Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Québec government for its recent decision to expand coverage of Dexcom Continuous Glucose Monitoring (CGM) Systems under the Régie de l’assurance maladie du Québec (RAMQ) for eligible Québecers aged 18 and older living with type 2 diabetes who are treated with intensi...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US6359061008
National Healthcare Corp
NHC
LISTED
XASE
NHC Announces Common Dividend
News Preview
National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 64 cents per common share to shareholders of record on December 31, 2025 and payable on January 30, 2026.
Forward-Looking Statements
Statements in this press release tha...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline.SO WHAT: I...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Grant & Eisenhofer Files Class Action Lawsuit Against Inspire Medical Systems, Inc.
News Preview
Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of City of Pontiac Reestablished General Employees’ Retirement System against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) and three of the Company’s senior executives, including CEO Timothy Herbert, CFO Richard Buchholz, and Chief Strategy and Growth O...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 21, 2025, the Compensation Committee of Guardant’s Board of Directors approved the granting of restricted stock units (“RSUs”) representing 184,961 shares of its common stock to 272 new non-executive employees and one non-qualified stock optio...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
ROSEN, SKILLED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DXCM
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the "Class Period") of the important December 29, 2025 lead plaintiff deadline.SO WHAT: If you purc...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK
News Preview
New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline.SO WHAT: If yo...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter International, Inc. DEADLINE ALERT: Baxter International, Inc. Investors Urged to Contact Kirby McInerney LLP About Class Action Lawsuit
News Preview
Kirby McInerney LLP reminds Baxter International, Inc. (“Baxter” or the “Company”) (NYSE:BAX) investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action.
If you purchased or otherwise acquired Baxter International, Inc. securities, have information, or would like to learn more, plea...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US28617K1016
Eledon Pharmaceuticals, Inc.
ELDN
LISTED
NASDAQ
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
News Preview
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the ASN Kidney Week...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US00972D1054
Akebia Therapeutics Inc
AKBA
LISTED
NASDAQ
Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs
News Preview
Win-Odds Analysis Presented at American Society of Nephrology Kidney Week 2025 Win-Odds Analysis Presented at American Society of Nephrology Kidney Week 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purch...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
News Preview
Phase 3 AQUILA study showed DARZALEX FASPRO® significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to active monitoring
Landmark approval supports earlier intervention and disease interception of multiple myel...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US0373261058
AN2 Therapeutics Inc
ANTX
LISTED
NASDAQ
AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference
News Preview
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO, will participate in a fireside chat at the 8th Annual Evercore HealthCONx Conference being he...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US58468P2065
MediciNova Inc
MNOV
LISTED
NASDAQ
MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
News Preview
LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that the company has been selected as a winner of the “Contract Research and Development Innovation Award” at the Fift...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.
About Thermo Fisher Scientific
Thermo Fisher Scientific I...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US74017N1054
Precigen Inc
PGEN
LISTED
NASDAQ
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
News Preview
GERMANTOWN, Md., Nov. 6, 2025 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the Company will release third quarter 2025 financial results and provide business updates on...
Themefolio
Profiler
Peergroup
© Newsfile
06.11.2025
ISIN: CA62858B1085
MyndTec Inc.
MYTC
LISTED
CSE
James Anderson Provides Update on Holdings of Myndtec Inc.
News Preview
Detroit, Michigan--(Newsfile Corp. - November 6, 2025) - James Anderson (the "Investor") announces update to his ownership of common shares in the capital of MyndTec Inc. (the "Issuer") (the "Common Shares") and common share purchase warrants of the Issuer (the "Warrants").On November 4, 2025, the Issuer completed the seventh tranche (the "Seventh...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US04280A1007
Arrowhead Pharmaceuticals Inc
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Year-End Results
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on November 25, 2025, at 4:30 p.m. ET to discuss its financial results for the 2025 fiscal year ended September 30, 2025.
Webcast and Conference Call Details
Investors may access a live audio webcast on the Events and Presentations page...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US20603L1026
Concentra Group Holdings Parent, Inc.
CON
LISTED
NASDAQ
Concentra Group Holdings Parent, Inc. Announces Results For Its Third Quarter Ended September 30, 2025, Cash Dividend, and Raised FY 2025 Guidance
News Preview
Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation’s largest provider of occupational health services, today announced results for its third quarter ended September 30, 2025, the declaration of a cash dividend, and raised guidance for full year 2025.
“2025 has continued to be an excell...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific Declares Quarterly Dividend
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on January 15, 2026, to shareholders of record as of December 15, 2025.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leade...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US5926881054
Mettler-Toledo International Inc
MTD
LISTED
NYSE
Mettler-Toledo International Inc. Reports Third Quarter 2025 Results
News Preview
Mettler-Toledo International Inc. (NYSE: MTD) today announced third quarter results for 2025. Provided below are the highlights:
Reported sales increased 8% compared with the prior year. In local currency, sales increased 6% compared with the prior year.
Net earnings per diluted share as reported (EPS) were $10.57, compared with $9.96 in the p...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
News Preview
MLTX Investors with Losses Encouraged to Contact Hagens Berman
SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: MLTX) announced disastrous Phase 3 tri...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Arizona Complete Health Offers Health Insurance in Arizona in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Arizona Complete Health plans in nine counties.
PHOENIX, Nov. 6, 2025 /PRNewswire/ -- Ambetter from Arizona Complete Health, a product offered by a Centene Corporation (NYSE: CNC) company, a...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
NEW YORK, Nov. 6, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
